|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Costs of revenues | |||||
| Gross loss | |||||
| Operating expenses: | |||||
| Research and development, net | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Financial income, net | |||||
| Net loss | |||||
| Basic net loss per ordinary share (in Dollars per share) | |||||
| Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares) | |||||
| Diluted net loss per ordinary share (in Dollars per share) | |||||
| Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares) | |||||
Loading...